Filtered By:
Management: Economics

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 211 results found since Jan 2013.

Feds try to clarify meaningful use attestation, hardship rules
WASHINGTON – Feeling confused about how to attest to meaningful use or how to claim a hardship exemption in 2014? You’re not alone. Federal officials say they’ve gotten lots of questions and comments in the wake of allowing flexibility on the <a...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 18, 2014 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CPN Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics PED Practice Economics RHEUM Practice Economics Source Type: news

PODCAST: Open Season for the ACA
Nov. 15 marked the opening of the second year of enrollment in Affordable Care Act marketplace plans. Just ahead of the rollout, HHS Secretary Sylvia Burwell pronounced the healthcare.gov web portal ready for business, having been tested over 5 weeks, as...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 17, 2014 Category: Dermatology Tags: CARD Podcasts CARD Practice Economics CHEST Podcasts CHEST Practice Economics CEN Podcasts CEN Practice Economics CNN Podcasts CNN Practice Economics CPN Podcasts Source Type: news

Court: Patients can sue over HIPAA breaches
Patients can sue doctors for negligence after alleged patient privacy breaches, the Connecticut Supreme Court has ruled in a decision that could have nationwide implications. The state’s highest court concluded that HIPAA does not preempt claims for emotional distress or negligence under state...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 14, 2014 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news

IOM recommends social factors to include in EHRs
Electronic health records should be equipped to record and track 12 social and behavioral determinants of health, an Institute of Medicine committee recommended. In addition to measures that are routinely collected now – race/ethnicity, tobacco use, alcohol use, and residential address – the...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 14, 2014 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics FPN Practice Economics EM Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news

Medicare expanding coverage of telehealth services
Medicare will begin paying for more care delivered by telehealth next year, but restrictions could limit the growth in these virtual or remote visits. The program pays for telehealth services only when provided in designated Health Professional Shortage Areas; additionally, patients must receive...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 12, 2014 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics FPN Practice Economics IMN Practice Economics PED Practice Economics RHEUM Practice Economics SAN Practice Economics Source Type: news

HHS cuts 2015 ACA enrollment estimates by a quarter
Federal health officials expect that somewhere between 9 million and 9.9 million individuals will have obtained health insurance through the Affordable Care Act marketplaces by the end of the 2015 open enrollment period, down from a previous government estimate of 13 million. The 9 million to 9.9...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - November 10, 2014 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news

The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial
Conclusions The results provide robust evidence to support non-inferiority of NLC in the management of RA. Trial registration ISRCTN29803766
Source: Annals of the Rheumatic Diseases - October 5, 2014 Category: Rheumatology Authors: Ndosi, M., Lewis, M., Hale, C., Quinn, H., Ryan, S., Emery, P., Bird, H., Hill, J. Tags: Open access, Immunology (including allergy), Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis, Epidemiology, Health economics Clinical and epidemiological research Source Type: research

Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects
Intravenous immunoglobulin therapy is of proven effect in chronic inflammatory neuropathies, including chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). In more recent years, there have been a number of anecdotal case reports and small series, followed by a few trials of variable design, of subcutaneous immunoglobulin therapy in these neuropathies. To date, limited evidence suggests that the subcutaneous route may be a more clinically effective, better-tolerated, at least cost-equivalent and a more patient-friendly option than the still more used intravenous alternative. Long-t...
Source: Journal of Neurology, Neurosurgery and Psychiatry - May 6, 2014 Category: Neurosurgery Authors: Rajabally, Y. A. Tags: Immunology (including allergy), Neuromuscular disease, Peripheral nerve disease Source Type: research

Sublingual immunotherapy improves symptoms of allergical rhinoconjunctivitis and asthma
Commentary on: Lin SY, Erekosima N, Kim JM, et al.. Sublingual immunotherapy for the treatment of allergical rhinoconjunctivitis and asthma: a systematic review. JAMA 2013;309:1278–88. Context Allergical rhinoconjunctivitis (ARC) and asthma are among the most prevalent chronic disorders affecting the US population, and contribute significantly to morbidity, direct and indirect healthcare costs and quality-of-life issues. Specific immunotherapy remains as a mainstay of treatment for these diseases and has traditionally been administered subcutaneously over an extended treatment period to desensitise allergical patient...
Source: Evidence-Based Medicine - January 22, 2014 Category: Internal Medicine Authors: Gentile, D. A. Tags: EBM Aetiology, Health policy, Clinical trials (epidemiology), Epidemiologic studies, Immunology (including allergy), Ophthalmology, Asthma, Ear, nose and throat/otolaryngology, Health economics, Health service research Source Type: research

Guidelines on glucose self-monitoring in non-insulin users are not evidence-based
Commentary on: Aakre KM, Watine J, Bunting PS, et al.. Self-monitoring of blood glucose in patients with diabetes who do not use insulin—are guidelines evidence-based? Diabet Med 2012;29:1226–36. Context There is controversy over the use of self-monitoring blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) not taking insulin. SMBG for patients taking insulin is supported by necessity to closely monitor glucose and potential fluctuations. Many individuals with T2DM use SMBG to guide treatment decisions while others use SMBG to fulfil clinician recommendations to check blood glucose levels. Sin...
Source: Evidence-Based Medicine - November 21, 2013 Category: Internal Medicine Authors: Kirk, J. K. Tags: Health policy, Clinical trials (epidemiology), Immunology (including allergy), Pregnancy, Health economics, Health service research, Diabetes, Guidelines Practice guideline Source Type: research

Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study
Conclusions: Food allergy is associated with higher health care costs. Severity of allergic symptoms is a key explanatory factor.
Source: The European Journal of Public Health - September 26, 2013 Category: Journals (General) Authors: Fox, M., Mugford, M., Voordouw, J., Cornelisse-Vermaat, J., Antonides, G., de la Hoz Caballer, B., Cerecedo, I., Zamora, J., Rokicka, E., Jewczak, M., Clark, A. B., Kowalski, M. L., Papadopoulos, N., Knulst, A. C., Seneviratne, S., Belohlavkova, S., Asero Tags: Food and nutrition Source Type: research

Network meta-analysis shows that prostaglandin inhibitors and nifedipine are best short-term tocolytics for preterm delivery
Commentary on: Haas DM, Caldwell DM, Kirkpatrick P, et al.. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012;345:e6226. Context Preterm birth is the leading cause of perinatal morbidity and mortality and a major source of healthcare costs. Despite advances in obstetrical care, the incidence of preterm birth is at an all-time high and may be rising due to increasing rates of advancing maternal age, maternal medical conditions, assisted reproductive technology and multiple gestations.1 Prevention of preterm birth and its associated neonatal morbidity and mortality are major concer...
Source: Evidence-Based Medicine - September 19, 2013 Category: Internal Medicine Authors: Abramovici, A., Jenkins, S. Tags: Journalology, Health policy, Clinical trials (epidemiology), Epidemiologic studies, Immunology (including allergy), Drugs: cardiovascular system, Pregnancy, Drugs: musculoskeletal and joint diseases, Health economics, Health service research Therapeutic Source Type: research

Negative pressure wound therapy (NPWT) for spinal wounds: a systematic review
Conclusions: Published reports are limited to small retrospective and case studies, with no reports of NPWT being used as a prophylactic treatment. Larger prospective RCTs of NPWT are needed to support the current evidence that it is effective in treating spinal wound complications. In addition, future studies should investigate its use as a prophylactic treatment to prevent infection and report data relating to safety and health economics.
Source: The Spine Journal - August 26, 2013 Category: Orthopaedics Authors: Karen J. Ousey, Ross A. Atkinson, J. Bradley Williamson, Steve Lui Tags: Review Articles Source Type: research

Allergy immunotherapy: what is the evidence for cost saving?
Purpose of reviewGiven the widespread prevalence of allergic disease, its substantially associated clinical and economic burden, the unique disease-modifying benefits of allergy immunotherapy (AIT), and increased availability of sublingual immunotherapy (SLIT), a critical update of the evidence for AIT-related cost savings [for both subcutaneous immunotherapy (SCIT) and SLIT] is particularly relevant and timely. The present article reviews the evidence for SCIT-related and SLIT-related cost savings derived from a systematic review of the published literature. Recent findingsExamined were 24 publications pertaining to the h...
Source: Current Opinion in Allergy and Clinical Immunology - May 23, 2013 Category: Allergy & Immunology Tags: PHARMACOTHERAPY AND EVIDENCE BASED MEDICINE: Edited by David A. Khan and Enrico Compalati Source Type: research

The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi
The objective of the present work was to determine cost-effectiveness thresholds for common paediatric cancers using acute lymphoblastic leukaemia (ALL) in Brazil and Burkitt lymphoma (BL) in Malawi as examples. Disability-adjusted life years (DALYs) prevented by treatment were compared to the gross domestic product (GDP) per capita of each country to define cost-effectiveness thresholds using WHO-CHOICE (‘CHOosing Interventions that are Cost-Effective’) guidelines. The case examples were selected due to the data available and because ALL and BL both have the potential to yield significant health gains at a low...
Source: Archives of Disease in Childhood - January 15, 2013 Category: Pediatrics Authors: Bhakta, N., Martiniuk, A. L. C., Gupta, S., Howard, S. C. Tags: Oncology, Health policy, Immunology (including allergy), Child health, Health economics, Health service research Global child health Source Type: research